Thi Huong Nguyen Ly, Choi Min-Jin, Shin Heung-Mook, Yang In-Jun
Department of Physiology, College of Korean Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.
R&D Center, Etnova Therapeutics Corp., 124, Sagimakgol-ro, Jungwon-gu, Gyeonggi-do 13207, Republic of Korea.
Evid Based Complement Alternat Med. 2022 Mar 23;2022:1307173. doi: 10.1155/2022/1307173. eCollection 2022.
Atopic dermatitis (AD) is a common inflammatory skin disease, which can be worsened under sleep deprivation (SD) conditions. This study investigated the efficacy and the mechanism of action of the traditional herbal formula Seungmagalgeun-tang (SMGGT) on the inflammation and behavioral changes in a mouse model of AD exposed to SD. SMGGT decreased levels of IgE, TNF-, IL-4, IL-13, and mast cell infiltration and reduced the expression of CD3 in the mouse skin. SMGGT also reversed the SD-induced increase in corticosterone and decrease in melatonin level. Furthermore, SMGGT reduced the immobility time in the tail suspension test significantly. HaCaT cells and HMC-1 cells were used to investigate the effects of SMGGT on cell signaling pathways. In TNF-/IFN- (TI) treated HaCaT cells, SMGGT reduced production of TARC/CCL17 and MDC/CCL22 and suppressed the p38 MAPK, STAT1, and NF-B pathways. In substance P (SP)/CRH-stimulated HMC-1 cells, SMGGT decreased VEGF production and inhibited ERK phosphorylation. Network pharmacology and molecular docking analysis revealed that puerarin and paeoniflorin might contribute to the effects of SMGGT by targeting several AD-related molecules and pathways. Puerarin and paeoniflorin exerted anti-inflammatory effects by decreasing production of MDC/CCL22 and IL-6 in TI-treated HaCaT cells and VEGF production in SP/CRH-stimulated HMC-1 cells. This study suggests that SMGGT with puerarin and paeoniflorin as main bioactive components alleviates skin inflammation and depression-like behavior in a sleep-deprived mouse model of AD.
特应性皮炎(AD)是一种常见的炎症性皮肤病,在睡眠剥夺(SD)条件下病情会加重。本研究调查了传统草药配方升麻葛根汤(SMGGT)对暴露于SD的AD小鼠模型炎症和行为变化的疗效及作用机制。SMGGT降低了小鼠皮肤中IgE、TNF-、IL-4、IL-13的水平以及肥大细胞浸润,并降低了CD3的表达。SMGGT还逆转了SD诱导的皮质酮增加和褪黑素水平降低。此外,SMGGT显著减少了尾悬测试中的不动时间。使用HaCaT细胞和HMC-1细胞研究SMGGT对细胞信号通路的影响。在TNF-/IFN-(TI)处理的HaCaT细胞中,SMGGT减少了TARC/CCL17和MDC/CCL22的产生,并抑制了p38 MAPK、STAT1和NF-κB通路。在P物质(SP)/促肾上腺皮质激素释放激素(CRH)刺激的HMC-1细胞中,SMGGT降低了VEGF的产生并抑制了ERK磷酸化。网络药理学和分子对接分析表明,葛根素和芍药苷可能通过靶向几种AD相关分子和通路发挥SMGGT的作用。葛根素和芍药苷通过减少TI处理的HaCaT细胞中MDC/CCL22和IL-6的产生以及SP/CRH刺激的HMC-1细胞中VEGF的产生发挥抗炎作用。本研究表明,以葛根素和芍药苷为主要生物活性成分的SMGGT可减轻睡眠剥夺的AD小鼠模型的皮肤炎症和抑郁样行为。